Summa Corp’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$738K Sell
3,020
-114
-4% -$26.6K 0.31% 38
2025
Q4
$649K Buy
3,134
+114
+4% +$22.5K 0.28% 38
2025
Q3
$560K Hold
3,020
0.25% 43
2025
Q2
$461K Hold
3,020
0.24% 46
2025
Q1
$501K Hold
3,020
0.29% 37
2024
Q4
$437K Hold
3,020
0.21% 44
2024
Q3
$489K Hold
3,020
0.23% 40
2024
Q2
$441K Hold
3,020
0.21% 42
2024
Q1
$478K Hold
3,020
0.26% 39
2023
Q4
$473K Buy
+3,020
New +$463K 0.33% 38

Other funds holding JNJ

Summa Corp's JNJ Position: Q1 2026 in Review

Summa Corp reduced its Johnson & Johnson (JNJ) stake by 3.6% in Q1 2026, selling an estimated $26.6K and leaving 3,020 shares worth $738K. The position accounts for 0.31% of the portfolio, ranked #38.

Summa Corp first reported a position in JNJ in Q4 2023 and has held it in 10 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Summa Corp held 3,020 shares of Johnson & Johnson worth $738K as of Q1 2026.
  • Summa Corp sold 114 Johnson & Johnson shares in Q1 2026, an estimated $26.6K.
  • Johnson & Johnson made up 0.31% of Summa Corp's portfolio in Q1 2026, its #38 holding.
  • Summa Corp first reported a position in Johnson & Johnson in Q4 2023 and has held it in 10 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Summa Corp's 13F filing for Q1 2026, filed 30 Apr 2026.